Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05041257
Title Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers (PICCOLO)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors ImmunoGen, Inc.
Indications

ovary epithelial cancer

fallopian tube cancer

peritoneum cancer

Therapies

Mirvetuximab Soravtansine

Age Groups: adult | senior
Covered Countries USA | ITA | ESP | CAN | BEL


No variant requirements are available.